Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
FDA Approves Targeted Lung Cancer Drug | Philadelphia News
FDA just approved a groundbreaking targeted therapy for a specific type of lung cancer, offering hope to patients with a particular genetic mutation. This precision treatment shrinks tumors and slows disease progression—with far fewer side effects than traditional chemo. Oncologists and patient advocates are thrilled but stress the need for genetic testing to find eligible patients. Years of research and collaboration led to this milestone, and follow-up studies are already exploring earlier use and combo therapies. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.